IP Library Assignment 031425/0017
Patent Assignment
Reel/Frame 031425/0017

Assignment of Assignor's Interest

Recorded: 2013-10-17 Pages: 3
Assignor
Assignee
ALETHIA BIOTHERAPEUTICS INC.
141 PRESIDENT-KENNEDY AVE, SB-5100, MONTREAL, H2X1Y4, CANADA
Covered Property (1)
Anti-Kidney Associated Antigen 1 (KAAG1) Antibodies
Patent: 9,855,291 →
Application: 13/127,439 →
Publication: US 2011/0223107
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 29, 2012
From: TREMBLAY, GILLES BERNARD; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 027952/0754 →
Assignment of Assignor's Interest Mar 29, 2012
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 027952/0500 →
Assignment of Assignor's Interest Jun 30, 2017
From: ALETHIA BIOTHERAPEUTICS INC.
To: ADC THERAPEUTICS SA
Reel/Frame 042880/0186 →
Security Interest May 19, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P., AS GRANTEE
Reel/Frame 052696/0247 →
Security Interest Jun 30, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P.
Reel/Frame 053094/0602 →
Termination and Release of Patent Security Agreement Aug 16, 2022
From: DEERFIELD PARTNERS, L.P.
To: ADC THERAPEUTICS SA
Reel/Frame 061200/0750 →
Patent Security Agreement Dec 27, 2022
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 062228/0763 →